Moreover, the results from the docking analysis (estimated ΔG and binding energy) suggest that compound 21 NP is the most stable and thermodynamically favorable for binding to the MAO-B active site, suggesting that such a compound should be more effective for PD treatment. This evidence concerns the gene MAOB and Parkinson disease.